Showing results (151-160 of 462) with videos related to

Sort By:
Pageof 47
Pharmacogenomics|November 3, 2017
An assessment of the impact of pharmacogenomics on health disparities: a systematic literature reviewAntony Martin, Jennifer Downing, Michelle Maden, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 14, 2018
Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohortRichard Myles Turner, Vanessa Fontana, Mark Bayliss, et al.
Annual Review of Pharmacology and Toxicology|April 12, 2005
The role of metabolic activation in drug-induced hepatotoxicityB Kevin Park, Neil R Kitteringham, James L Maggs, et al.
The Journal of Investigative Dermatology|August 28, 2009
Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified proteinClaire Jenkinson, Rosalind E Jenkins, Maja Aleksic, et al.
Biochemical and Biophysical Research Communications|April 26, 2011
The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoproteinMeike Vogler, David Dickens, Martin J S Dyer, et al.
Clinical Pharmacology and Therapeutics|December 17, 2025
Improving Genotype Imputation in High-Dimensional Pharmacogenomics Using Multiple Imputation: Evaluation with Machine Learning ApproachesInnocent G Asiimwe, Tao You, Daniel F Carr, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2010
Haplotype structure of CYP2B6 and association with plasma efavirenz concentrations in a Chilean HIV cohortDaniel F Carr, Charles J L la Porte, Munir Pirmohamed, et al.
The Cochrane Database of Systematic Reviews|July 18, 2019
Genetic testing for prevention of severe drug-induced skin rashAna Alfirevic, Munir Pirmohamed, Branka Marinovic, et al.
The Journal of Antimicrobial Chemotherapy|June 21, 2008
HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic optionsJane E Mallewa, Edmund Wilkins, Javier Vilar, et al.
Pageof 47